Trial Profile
A Double Blind, Randomised, Placebo Controlled Parallel Group Study of Cannabis Based Medicine Extract (CBME), in the Treatment of Peripheral Neuropathic Pain Characterised by Allodynia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Jan 2022
Price :
$35
*
At a glance
- Drugs Nabiximols (Primary)
- Indications Neuropathic pain; Peripheral neuropathies
- Focus Therapeutic Use
- Sponsors Jazz Pharmaceuticals Inc
- 12 Sep 2014 New trial record